Resolvin D 2 prevents secondary thrombosis and necrosis in a mouse burn wound model
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Deep partial thickness burns are subject to delayed necrosis of initially viable tissues surrounding the primary zone of thermally induced coagulation, which results in an expansion of the burn wound, both in area and depth, within 48 hours postburn. Neutrophil sequestration and activation leading to microvascular damage is thought to mediate this secondary tissue damage. Resolvins, a class of endogenous mediators derived from omega‐3 polyunsaturated fatty acids, have been shown to regulate the resolution of inflammation. We hypothesized that exogenous resolvins could mitigate the deleterious impact of the inflammatory response in burn wounds. Using two different mouse burn injury models involving significant partial thickness injuries, we found that a systemically administered single dose of resolvin D 2 (R v D 2) as low as 25 pg/g bw given within an interval of up to 4 hours postburn effectively prevented thrombosis of the deep dermal vascular network and subsequent dermal necrosis. By preserving the microvascular network, R v D 2 enhanced neutrophil access to the dermis, but prevented neutrophil‐mediated damage through other anti‐inflammatory actions, including inhibition of tumor necrosis factor‐α, interleukin‐1β, and neutrophil platelet–endothelial cell adhesion molecule‐1. In a clinical context, R v D 2 may be therapeutically useful by reducing the need for surgical debridement and the area requiring skin grafting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“In this study, we specifically focus on resolvin D2 (RvD2), which is endogenously produced by the sequential actions of 15-lipoxygenase and 5-lipoxygenase on docosahexaenoic acid, and whose stereochemistry (7S,16R,17S-trihydroxy4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid) has been confirmed by total organic synthesis.(…”
BackgroundInflammatory cells during wound repair: the good, the bad and the ugly
Martin, P., & Leibovich, S. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.09.002 · Cited by 1,340 · cited 1×
“This could effectively help “resolve” the inflammation and promote a transition from the inflammatory to the proliferative and remodeling phases of wound healing.(29) Therefore, the fact that RvD2 did not prevent neutrophil sequestration into the burn wounds seems paradoxical.”
BackgroundChen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876 · cited 1×
“A modified colorimetric myeloperoxidase (MPO) assay was performed as previously described.(21) In short, samples were exposed to three cycles of freeze-thawing in nondenaturing lysis buffer (TRIZMA, 10% glycerol, 0.”
MethodResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 3×
“RvD2 in particular proved protective in murine models of sepsis via its ability to regulate neutrophil infiltration, cytokine levels including TNF-a, the adhesive properties of vascular endothelial cells, and production of vasoactive mediators such as nitric oxide and prostacyclin.(14) In this study, we investigated t…”
Background
Cited by
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
R Hamblin, M., 1 Wellman Center for Photomedicine, M. G. H., 2 Department of Dermatology, H. M. S., & 3 Harvard-MIT Division of Health Sciences and Technology, C. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.3.337 · Cited by 1,265
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Metadata
- Authors
- Bohr, S., Patel, S. J., Sarin, D., Irimia, D., Yarmush, M. L., & Berthiaume, F.
- Venue
- Wound Repair and Regeneration
- Publisher
- Wiley
- Published
- 2012-10-30
- Volume
- 21
- Issue
- 1
- Pages
- 35-43
- ISSN
- 1067-1927 (ISSN-L)
- 1524-475X
- OpenAlex
- W1922526906
- Cited by
- 113
- References
- 4
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resolvin D 2 prevents secondary thrombosis and necrosis in a mouse burn wound model. https://app.cochat.ai/papers/10.1111/j.1524-475x.2012.00853.x
- The paper
- Bohr, S., Patel, S. J., Sarin, D., Irimia, D., Yarmush, M. L., & Berthiaume, F. (2013). Resolvin D 2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair and Regeneration. https://doi.org/10.1111/j.1524-475x.2012.00853.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.